Diffusion-weighted MRI of infarct growth in a rat photochemical stroke model: Effect of lubeluzole

Neuropharmacology

Volumn 39, Issue 4, 2000, Pages 691-702

  De Ryck, Marc ^a   Verhoye, Marleen ^b   Van Der Linden, Anne Marie ^b  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Apparent diffusion coefficient; Diffusion weighted MRI; Lubeluzole; Magnetic resonance imaging; Neuroprotection; Photochemical infarct

Indexed keywords

LUBELUZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; MALE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOCHEMISTRY; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; CEREBRAL INFARCTION; DIFFUSION; MAGNETIC RESONANCE IMAGING; MALE; MOTOR CORTEX; NEOCORTEX; NEUROPROTECTIVE AGENTS; PHOTOCHEMISTRY; PIPERIDINES; RATS; RATS, WISTAR; SOMATOSENSORY CORTEX; THIAZOLES;

EID: 0033975565     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00176-8     Document Type: Article

References (61)

1. Aronowski J., Strong R., Grotta J.C. Treatment of experimental focal ischemia in rats with lubeluzole. Neuropharmacology. 35:1996;689-693.
2. Baldwin H.A., Snape M.F., Williams J.L., Misra A., Jones J.A., Snares M., Green A.R., Cross A.J. The role of glutamate and GABA in a rat model of focal cerebral ischaemia: biochemical and pharmacological investigations. Neurodegeneration. 2:1993;129-138.
3. Baldwin H.A., Williams J.L., Snares M., Ferreira T., Cross A.J., Green A.R. Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. British Journal of Pharmacology. 112:1994;188-194.
4. Belayev L., Busto R., Zhao W., Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Research. 739:1996;88-96.
5. 2+ antagonist, is neuroprotective in two models of cerebral ischaemia. Neuropharmacology. 32:1993;1249-1257.
6. Benveniste H., Hedlund W., Johnson G.A. Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy. Stroke. 23:1992;746-754.
7. Buchkremer-Ratzmann I., Witte O.W. Pharmacological reduction of electrophysiological diaschisis after photothrombotic ischemia in rat neocortex. European Journal of Pharmacology. 320:1997;103-109.
8. Busza A.L., Allen K.L., King M.D., van Bruggen N., Williams S.R., Gadian D.G. Diffusion-weighted imaging studies of cerebral ischemia in gerbils, potential relevance to energy failure. Stroke. 23:1992;1602-1612.
9. De Ryck M., Van Reempts J., Borgers M., Wauquier A., Janssen P.A.J. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke. 20:1989;1383-1390.
10. De Ryck M., Van Reempts J., Duytschaever H., Van Deuren B., Clincke G. Neocortical localization of tactile/proprioceptive limb placing reactions in the rat. Brain Research. 573:1992;44-60.
11. De Ryck M., Keersmaekers R., Duytschaever H., Claes G., Clincke G., Janssen M., Van Reet G. Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats. Journal of Pharmacological Experimental Theory. 279:1996;748-758.
12. Dietrich W.D., Busto R., Watson B.D., Scheinberg P., Ginsberg M.D. Photochemically induced cerebral infarction. II: Edema and blood-brain barrier disruption. Acta Neuropathology. 72:1987;326-334.
13. Dietrich W.D., Ginsberg M.D., Busto R., Watson B.D. Photochemically induced cortical infarction in the rat. 2. Acute and subacute alterations in local glucose utilization. Journal of Cerebral Blood Flow Metabolism. 6:1986;195-202.
14. Ebisu T., Naruse S., Horikawa Y., Satoshi U., Tanaka C., Mitsuhiro U., Umeda M., Higuchi T. Discrimination between different types of white matter edema with diffusion-weighted MR imaging. JMRI. 3:1993;863-868.
15. Gass P., Spranger M., Herdegen T., Bravo R., Köck P., Hacke W., Kiessling M. Induction of FOS and JUN proteins after focal ischemia in the rat: differential effect of the N-methyl-D-aspartate receptor antagonist MK-801. Acta Neuropathology. 84:1992;545-553.
16. Gill R., Sibson N.R., Hatfield R.H., Burdett N.G., Carpenter T.A., Hall L.D., Pickard J.D. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. Journal of Cerebral Blood Flow Metabolism. 15(4):1995;602-610.
17. Grome J.J., Gojowczyk G., Hofmann W., Graham D.I. Quantitation of photochemically induced focal cerebral ischemia in the rat. Journal of Cerebral Blood Flow Metabolism. 8:1988;89-95.
18. Hall W.L., Benveniste H., Hedlung L.W., Johnson G.A. A new in vivo method for quantitative analysis of stroke lesions using MR microscopy. NeuroImage. 3:1996;158-166.
19. Hasegawa Y., Latour L.L., Sotak C.H., Dardzinski B.J., Fisher M. Temperature dependent change of apparent diffusion coefficient of water in normal and ischemic brain of rats. Journal of Cerebral Blood Flow Metabolism. 14:1994;383-390.
20. Hoehn-Berlage M., Norris D.G., Kohno K., Mies G., Leibfritz D., Hossmann K.-A. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. Journal of Cerebral Blood Flow Metabolism. 15:1995;1002-1011.
21. 2) and apparent diffusion coefficient after permanent middle cerebral artery occlusion in the rat: temporal evolution, regional extent, and comparison with histology. MRM. 34:1995;824-834.
22. Hoehn-Berlage M., Eis M., Schmitz B. Regional and directional anisotropy of apparent diffusion coefficient in rat brain. NMR in Biomedicine. 12:1999;45-50.
23. Hossmann K.A. Viability thresholds and the penumbra of focal ischemia. Annuals of Neurology. 36:1994;557-565.
24. Hossmann K.A., Hoehn-Berlage M. Diffusion and perfusion MR imaging of cerebral ischemia. Cerebrovascular Brain Metabolism Review. 17:1995;187-217.
25. Kharlamov A., Guidotti A., Costa E., Hayes R., Armstrong D. Semisynthetic sphingolipids prevent protein kinase C translocation and neuronal damage in the perifocal area following a photochemically induced thrombotic brain cortical lesion. Journal of Neuroscience. 13:1993;2483-2494.
26. Knight R.A., Ordidge R.J., Helpern J.A., Chopp M., Rodolosi L.C., Peck D. Temporal evolution of ischemic damage in rat brain measured by proton nuclear magnetic resonance imaging. Stroke. 22:1991;802-808.
27. Kucharczyk J., Chew W., Derugin N., Moseley M., Rollin C., Berry I., Norman D. Nicardipine reduces ischemic brain injury, magnetic resonance imaging/spectroscopy study in cats. Stroke. 20:1989;268-274.
28. Kucharczyk J., Mintorovitch J., Asgari H.S., Moseley M. Diffusion/perfusion MR imaging of acute cerebral ischemia. Magnetic Resonance Medicine. 19:1991;311-315.
29. Kucharczyk J., Mintorovitch J., Moseley M.E., Asgari H.S., Sevick R.J., Derugin N., Norman D. Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476. Radiology. 179:1991;221-227.
30. 2- and postcontrast T1-weighted NMR images for the sequential monitoring of focal ischemic lesions in the rat brain. MRI. 11:1993;675-683.
31. 2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain. MRI. 13:1995;185-192.
32. Laurent D., Eis M., Sauer D., Theilkaes W., Allegrini P.R. Reduction of excitotoxicity-induced brain damage by the competitive NMDA antagonist CGP40116: a longitudinal study using diffusion-weighted imaging. Neuroscience Letters. 213:1996;209-212.
33. Lee V.M., Burdett N.G., Carpenter T.A., Hall L.D., Pambakian P.S., Patel S., Wood N.I., James M.F. Evolution of photochemically induced focal cerebral ischemia in the rat, magnetic resonance imaging and histology. Stroke. 27:1996;2110-2118.
34. Lesage A.S., Peeters L., Leysen J.E. Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway. Journal of Pharmacological Experimental Theory. 279:1996;759-766.
35. Lo E.H., Matsumoto K., Pierce A.R., Garrido L., Luttinger D. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. Journal of Cerebral Blood Flow Metabolism. 14:1994;597-603.
36. Lo E.H., Pierce A.R., Mandeville J.B., Rosen B.R. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke. 28:1997;439-446.
37. 2 MR imaging. MRI. 15:1997;1045-1055.
38. Lythgoe M.F., Busza A.L., Calamante F., Sotak C.H., King M.D., Bingham A.C., Williams S.R., Gadian D.G. Effects of diffusion anisotropy on lesion delineation in a rat model of cerebral ischemia. MRM. 38:1997;662-668.
39. Minematsu K., Li L., Fisher M., Sotak C.H., Davis M.A., Fiandaca M.S. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology. 42:1992;235-240.
40. Minematsu K., Fisher M., Li L., Davis M.A., Knapp A.G., Cotter R.E., McBurney R.N., Sotak C.H. Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology. 43:1993;397-403.
41. 2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magnetic Resonance Medicine. 18:1991;39-50.
42. 2-weighted MRI and spectroscopy. Magnetic Resonance Medicine. 14:1990;330-346.
43. Perez-Pinzon M.A., Yenari M.A., Sun G.H., Kunis D.M., Steinberg G.K. SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits. Journal of Neurological Science. 153:1997;25-31.
44. Pierpaoli C., Righini A., Linfante I., Tao-Cheng H.J., Alger J.R., Di Chiro G. Histopathologic correlates of abnormal water diffusion in cerebral ischemia: diffusion-weighted MR Imaging and light and electron microscopic study. Neuroradiology. 189:1993;439-448.
45. Qiu H., Hedlund L.W., Gewalt S.L., Benveniste H., Bare T.M., Johnson G.A. Progression of a focal ischemic lesion in rat brain during treatment with a novel glycine/NMDA antagonist: an in vivo three-dimensional diffusion-weighted MR microscopy study. Journal of Magnetic Resonance Imaging. 7:1997;739-744.
46. Reith W., Hasegawa Y., Latour L.L., Dardzinski B.J., Sotak C.H., Fisher M. Multislice diffusion mapping for 3-D evolution of cerebral ischemia in a rat stroke model. Neurology. 45:1995;172-177.
47. Rordorf G., Koroshetz W.J., Copen W.A., Cramer S.C., Schaefer P.W., Budzik R.F. Jr., Schwamm L.H., Buonanno F., Sorensen A.G., Gonzalez G. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke. 29:1998;939-943.
48. Roussel S.A., van Bruggen N., King M.D., Houseman J., Williams S.R., Gadian D.G. Monitoring the initial expansion of focal ischemic changes by diffusion-weighted MRI using a remote controlled method of occlusion. NMR in Biomedicine. 7:1994;21-28.
49. Sauer D., Allegrini P.R., Cosenti A., Pataki A., Amacker H., Fagg G.E. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study. Journal of Cerebral Blood Flow Metabolism. 13:1993;595-602.
50. Sauer D., Weber E., Luond G., Da Silva F., Allegrini P.R. The competitive NMDA antagonist CGP 40116 permanently reduces brain damage after middle cerebral artery occlusion in rats. Journal of Cerebral Blood Flow Metabolism. 15:1995;1-11.
51. Sauter A., Rudin M. Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. Stroke. 17:1986;1228-1234.
52. Scheller D.K.A., De Ryck M., Kolb J., Szathmary S., Van Reempts J., Clincke G., Tegtmeier F. Lubeluzole blocks increases in extracellular glutamate and taurine in the peri-infarct zone in rats. European Journal of Pharmacology. 338:1997;243-251.
53. Snape M.F., Baldwin H.A., Cross A.J., Green A.R. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience. 53:1993;837-844.
54. Takano K., Tatlisumak T., Formato J.E., Carano R.A.D., Bergmann A.G., Pullan L.M., Bare T.M., Sotak C.H., Fisher M. Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies. Stroke. 28:1997;1255-1262.
55. Tatlisumak T., Takano K., Carano R.A., Fisher M. Effect of basic fibroblast growth on experimental focal ischemia studied by diffusion-weighted and perfusion imaging. Stroke. 27:1996;2292-2297.
56. 2- and Diffusion-Weighted Magnetic Resonance Imaging of a Focal Ischemic lesion in rat brain. Stroke. 23:1991;577-582.
57. Van Gelderen P., de Vleeschouwer M.H.M., DesPres D., Pekar J., van Zijl P.C.M., Moonen C.T.W. Water diffusion and acute stroke. Magnetic Resonance Medicine. 31:1994;154-163.
58. Verheul H.B., Balazs R., Berkelbach van der Sprenkel J.W., Tulleken C.A.F., Nicolay K., Tamminga K.S., van Lookeren Campagne M. Comparison of diffusion-weighted MRI with changes in cell volume in a rat model of brain injury. NMR in Biomedicine. 7:1994;96-100.
59. Warach S., Chien D., Li W., Ronthal M., Edelman R.R. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology. 42:1992;1717-1723.
60. Warach S., Dashe J.F., Edelman R.R. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. Journal of Cerebral Blood Flow Metabolism. 16:1996;53-59.
61. Watson B.D., Dietrich W.D., Busto R., Wachtel M.S., Ginsberg M.D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Annuals of Neurology. 17:1985;497-504.